Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA
To date, no medical therapy can slow the progression of aortic stenosis. Fibrocalcific stenosis is the most frequent form in the general population and affects about 6% of the elderly population. Over the years, diagnosis has evolved thanks to echocardiography and computed tomography assessments. Th...
Main Authors: | Assunta Di Costanzo, Ciro Indolfi, Anna Franzone, Giovanni Esposito, Carmen Anna Maria Spaccarotella |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/19/14939 |
Similar Items
-
Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
by: Clarice Gareri, et al.
Published: (2022-07-01) -
Aortic Stenosis Phenotypes and Precision Transcatheter Aortic Valve Implantation
by: Muzamil Khawaja, et al.
Published: (2023-06-01) -
Hemodynamic Performance of Two Current-Generation Transcatheter Heart Valve Prostheses in Severely Calcified Aortic Valve Stenosis
by: Max Potratz, et al.
Published: (2022-08-01) -
From an Unfolding Emergency Treatment to a Universal Shift in Therapy: The History and Evolution of the Catheter-Based Treatment of Aortic Valve Stenosis
by: Hüseyin Umut Agma, et al.
Published: (2022-10-01) -
LIPID PROFILE AND CALCIUM AND PHOSPHATE METABOLISM IN PATIENTS WITH CORONARY HEART DISEASE AND AORTIC STENOSIS
by: O. A. Rodicheva, et al.
Published: (2012-12-01)